HeartSciences (HSCSW) Cash from Operations (2021 - 2026)

HeartSciences (HSCSW) has reported Cash from Operations for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations fell 5.4% year-over-year to -$1.7 million; the trailing twelve-month figure through Apr 2026 stood at -$7.6 million (down 1.91% YoY), and the FY2026 full-year result was -$7.4 million, changed 0.18% from the prior year.
• Cash from Operations grew to -$1.7 million in Q2 2026 per HSCSW's latest filing, from -$2.3 million in the prior quarter.
• Across five years, Cash from Operations topped out at -$966278.0 in Q1 2022 and bottomed at -$2.3 million in Q4 2025.
• Historically, Cash from Operations has averaged -$1.6 million across 5 years, with a median of -$1.6 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations slumped 152.51% in 2022, then climbed 22.89% in 2025.
• Over 5 years, Cash from Operations stood at -$1.1 million in 2022, then grew by 8.51% to -$988187.0 in 2023, then sank by 120.97% to -$2.2 million in 2024, then slipped by 6.9% to -$2.3 million in 2025, then climbed by 28.18% to -$1.7 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered -$1.7 million, -$2.3 million, and -$2.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.